nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Editorial Board
|
|
|
|
126 |
17 |
p. i |
artikel |
2 |
Erythroferrone contributes to hepcidin suppression and iron overload in a mouse model of β-thalassemia
|
Kautz, Léon |
|
|
126 |
17 |
p. 2031-2037 |
artikel |
3 |
Erythroferrone: the missing link in β-thalassemia?
|
Moura, Ivan C. |
|
|
126 |
17 |
p. 1974-1975 |
artikel |
4 |
Hemostatic efficacy, safety, and pharmacokinetics of a recombinant von Willebrand factor in severe von Willebrand disease
|
Gill, Joan C. |
|
|
126 |
17 |
p. 2038-2046 |
artikel |
5 |
Hepatosplenic T-cell lymphoma mimicking bone marrow metastasis
|
Benayoun, Emmanuel |
|
|
126 |
17 |
p. 2071 |
artikel |
6 |
Hypoxia-recruited angiogenic neutrophils
|
Campbell, Eric L. |
|
|
126 |
17 |
p. 1972-1973 |
artikel |
7 |
Identification and characterization of VEGF-A–responsive neutrophils expressing CD49d, VEGFR1, and CXCR4 in mice and humans
|
Massena, Sara |
|
|
126 |
17 |
p. 2016-2026 |
artikel |
8 |
Mice expressing a mutant form of fibrinogen that cannot support fibrin formation exhibit compromised antimicrobial host defense
|
Prasad, Joni M. |
|
|
126 |
17 |
p. 2047-2058 |
artikel |
9 |
No CLL transmission through blood transfusion
|
Landgren, Ola |
|
|
126 |
17 |
p. 1978-1979 |
artikel |
10 |
Nodal extramedullary hematopoiesis and facial bone change in thalassemia
|
Daneshbod, Yahya |
|
|
126 |
17 |
p. 2070 |
artikel |
11 |
No evidence of transmission of chronic lymphocytic leukemia through blood transfusion
|
Hjalgrim, Henrik |
|
|
126 |
17 |
p. 2059-2061 |
artikel |
12 |
Not fibrin(ogen), but fibrinogen or fibrin
|
Litvinov, Rustem I. |
|
|
126 |
17 |
p. 1977-1978 |
artikel |
13 |
Oral iron supplements increase hepcidin and decrease iron absorption from daily or twice-daily doses in iron-depleted young women
|
Moretti, Diego |
|
|
126 |
17 |
p. 1981-1989 |
artikel |
14 |
Ouseph MM, Huang Y, Banerjee M, et al. Autophagy is induced upon platelet activation and is essential for hemostasis and thrombosis. Blood. 2015;126(10):1224-1233.
|
|
|
|
126 |
17 |
p. 2072 |
artikel |
15 |
Outcome of patients with distinct molecular genotypes and cytogenetically normal AML after allogeneic transplantation
|
Schmid, Christoph |
|
|
126 |
17 |
p. 2062-2069 |
artikel |
16 |
Overexpression and knockout of miR-126 both promote leukemogenesis
|
Li, Zejuan |
|
|
126 |
17 |
p. 2005-2015 |
artikel |
17 |
Paris-Trousseau: evidence keeps pointing to FLI1
|
Di Paola, Jorge |
|
|
126 |
17 |
p. 1973-1974 |
artikel |
18 |
Paris-Trousseau thrombocytopenia is phenocopied by the autosomal recessive inheritance of a DNA-binding domain mutation in FLI1
|
Stevenson, William S. |
|
|
126 |
17 |
p. 2027-2030 |
artikel |
19 |
Prediction of high- and low-risk multiple myeloma based on gene expression and the International Staging System
|
Kuiper, Rowan |
|
|
126 |
17 |
p. 1996-2004 |
artikel |
20 |
Risk of familial classical Hodgkin lymphoma by relationship, histology, age, and sex: a joint study from five Nordic countries
|
Kharazmi, Elham |
|
|
126 |
17 |
p. 1990-1995 |
artikel |
21 |
rVWF: treatment finally reaches the modern age
|
Metjian, Ara D. |
|
|
126 |
17 |
p. 1975-1976 |
artikel |
22 |
So you know how to treat iron deficiency anemia
|
Schrier, Stanley L. |
|
|
126 |
17 |
p. 1971 |
artikel |
23 |
Walz S, Stickel JS, Kowalewski DJ, et al. The antigenic landscape of multiple myeloma: mass spectrometry (re)defines targets for T-cell–based immunotherapy. Blood. 2015;126(10):1203-1213.
|
|
|
|
126 |
17 |
p. 2072-2073 |
artikel |